ArticleJournal of enzyme inhibition and medicinal chemistry2022

Development of newly synthesised quinazolinone-based CDK2 inhibitors with potent efficacy against melanoma.

Eman R Mohammed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.